Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection

Recruiting Observational Study
Infectious Keratitis Microbial Keratitis Corneal Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
46 (estimated)
Sponsor
CHU de Reims · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological conf…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Over 18 years old * With social security affiliation * Willing to participate this study * Hospitalized in our department for severe infectious keratitis Non-inclusion criteria: * Any prior (48 hours) or concomitant treatment with local or systemic antibiotherapy at time of …
Contacts

Alexandre DENOYER

03 26 78 78 88

adenoyer@chu-reims.fr

CONTACT

Thomas Ferreira de Moura

03 26 78 78 88

tferreira-de-moura@chu-reims.fr

CONTACT